
Jayson Slotnik, JD, MPH
Founding Partner, Health Policy Strategies
Jayson counsels biotech, pharmaceutical, device, and diagnostic companies on how Medicare and Medicaid coverage, payment, reimbursement, coding, and broader government policy affect commercial success.
Background
- First Director, Medicare Reimbursement and Economic PolicyBiotechnology Industry Organization (BIO)
- Health law practiceTwo Washington, D.C. law firms
- Vice President, Reimbursement and Innovation StrategiesUnited BioSource Corporation
- Board memberAssociation for Value-Based Cancer Care
- Podcast hostAVBCC Value-Based Voices
- Editorial boardsValue-Based Cancer Care; Specialty Pharmacy Times
- Washington Insights columnistSpecialty Pharmacy Times
Education
- JD, Health Law, University of Maryland School of Law
- MPH, Epidemiology and Biostatistics, The George Washington University
- BA, English, University of Rochester

